Efficacy and Safety of Rectally Administered BBT-401-1S in Subjects With Ulcerative Colitis
Clinical trial NCT04478825 · TERMINATED
Trial details
- NCT number
- NCT04478825
- Sponsor
- Bridge Biotherapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-01
- Primary completion
- 2021-08-04
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.